Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival

Publication date

2022-02-09

Authors

Levink, Iris J M
Brosens, Lodewijk AORCID 0000-0003-1341-8994
Rensen, Sander S
Aberle, Merel R
Olde Damink, Steven S W
Cahen, Djuna L
Buschow, Sonja I
Fuhler, Gwenny M
Peppelenbosch, Maikel P
Bruno, Marco J

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by

Abstract

Introduction: Factors underlying antitumor immunity in pancreatic cancer (PC) are poorly understood. We hypothesized that not neoantigen quantity, but quality, is related to immune cell infiltration and survival. Methodology: We performed genomic and transcriptomic profiling of paired normal, tumor tissue of 13 patients with PC with distinct survival times. Additionally, neoantigens prediction and immunological profiling were performed. Results: The proportion of neoantigens with a low similarity-to-self score was higher in short-term survivors (p < 0.0001), while mutational load and burden, similarity-to-known-pathogens, and immunogenicity of neoantigens were not associated with immune cell infiltration or survival. Discussion: No tumor mutational load or neoantigen quantity, but low similarity-to-self score, was associated with immune cell infiltration and survival.

Keywords

cancer immunity, chromosomal instability disorders, mutation–genetics, neoantigen and shared-antigen vaccine, pancreatic cancer, General Medicine

Citation

Levink, I J M, Brosens, L A A, Rensen, S S, Aberle, M R, Olde Damink, S S W, Cahen, D L, Buschow, S I, Fuhler, G M, Peppelenbosch, M P & Bruno, M J 2022, 'Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival', Frontiers in medicine, vol. 8, 751110, pp. 1-7. https://doi.org/10.3389/fmed.2021.751110